Therapeutic Goods Administration

Part of the department, Health, Disability and Ageing portfolio. Part of Department of Health, Disability and Ageing.

When Therapeutic Goods Administration appeared at Senate Estimates: 7 sessions in 2 hearings, 1 h 25 min at the table; mentioned 12 times.

Topics raised: Health, Public safety, International law, Government advertising, Law reform, Public service staffing, Cost recovery, Integrity

Supplementary Budget Estimates 2026–27

• Community Affairs 29 Oct 2026
  • 29:52 to 39:05 (9 min, low confidence)
    • Introduction of TGA and Health Agencies
    • TGA Guidance on Medicine Advertising in Media
  • 54:04 to 58:01 (4 min, low confidence)
    • RSV Vaccine Safety and Pharmacovigilance Monitoring
  • 1:03:47 to 1:17:01 (13 min, low confidence)
    • COVID-19 Vaccine Safety and Spike Protein Testing
  • 1:29:51 to 1:37:26 (8 min, low confidence)
    • TGA Registration of Novel Health Therapies
  • 2:34:28 to 2:37:32 (3 min, low confidence)
    • Oversight of Medicinal Cannabis Expert Group

  Mentioned 9 times during other sessions.

• Community Affairs, part 2 28 Oct 2026
  • 3:09:32 to 3:18:31 (9 min, low confidence)
    • Childhood Vaccine Safety and Adverse Events
  • 3:53:31 to 4:35:19 (39 min, low confidence)
    • TGA Medical Device Regulation and Assessments
    • Australia's COVID-19 Vaccine Schedule and Sweden
    • Prescribing Hydroxychloroquine and Ivermectin for Influenza
    • TGA Advertising Rules and Media Reporting
    • Mandatory Reporting and Medical Device Staffing

  Mentioned 1 times during other sessions.

• Economics 29 Oct 2026

  Mentioned 1 times during other sessions.

• Community Affairs 28 Oct 2026

  Mentioned 1 times during other sessions.